Monopar Therapeutics
Recent Filings
All 484 filings →| Form | Description | Date |
|---|---|---|
| 8-K | FORM 8-K | Mar 27, 2026 |
| 10-K | FORM 10-K | Mar 27, 2026 |
| 4 | FORM 4 | Mar 4, 2026 |
| 3 | FORM 3 | Mar 4, 2026 |
| 8-K | FORM 8-K | Mar 2, 2026 |
| SCHEDULE 13G/A | — | Feb 17, 2026 |
| SCHEDULE 13D/A | — | Jan 30, 2026 |
| 4 | FORM 4 | Jan 30, 2026 |
| 4 | FORM 4 | Jan 5, 2026 |
| 4 | FORM 4 | Jan 5, 2026 |
Insider Transactions
View all →| Insider | Title | Type | Shares | Owns After | Date |
|---|---|---|---|---|---|
| Vu Quan Anh | Chief Financial Officer | Purchase | 1,500 @ $69.95 | 1,500 | Dec 26, 2025 |
| KLAUSNER ARTHUR J | — | Sale | 461 @ $68.09 | 8,762 | Dec 18, 2025 |
| Tactic Pharma LLC | Chief Executive Officer | Sale | 550,229 @ $63.61 | 272,026 | Sep 24, 2025 |
| Tsuchimoto Kim R | — | Sale | 8,904 @ $40.00 | 11,486 | Jul 14, 2025 |
| Robinson Chandler | Chief Executive Officer | Sale | 16,800 @ $40.00 | 73,472 | Jul 14, 2025 |
| Brown Michael J | — | Sale | 33,334 @ $35.00 | 822,255 | Apr 2, 2025 |
| Radhakrishnan Karthik | Chief Financial Officer | Purchase | 1,550 @ $16.25 | 1,550 | Oct 28, 2024 |
| Cittadine Andrew | Chief Operating Officer | Purchase | 20,508 @ $0.74 | 186,132 | Jun 18, 2024 |
| Cittadine Andrew | Chief Operating Officer | Purchase | 12,000 @ $0.90 | 153,624 | Jun 13, 2024 |
| Cittadine Andrew | Chief Operating Officer | Purchase | 12,000 @ $0.78 | 117,624 | Jun 3, 2024 |